{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:52:00Z","timestamp":1794711120562,"version":"4.9.1"},"reference-count":47,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P2-0209"],"award-info":[{"award-number":["P2-0209"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Depression often co-occurs with Parkinson's disease (PD) and is effectively treated with selective serotonin reuptake inhibitors (SSRI) and serotonin and noradrenaline reuptake inhibitors (SNRI), but their effect on motor symptoms has not yet been conclusively demonstrated.\n                    <jats:bold>Objective:<\/jats:bold>\n                    To assess the impact of the SSRI\/SNRI on the motor symptoms of PD.\n                    <jats:bold>Methods:<\/jats:bold>\n                    We used data from the Parkinson's Progression Markers Initiative database, in a matched subject design with a target group (N\u2009=\u200947) which had been taking SSRI\/SNRI medication and a control group (N\u2009=\u200990) which had not. Matching criteria included Movement Disorders Society Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS-III) total score and its subscales\u2019 scores, and levodopa equivalent daily dose (LEDD) at the time of the first examination (initial LEDD). For the target group, we compared the MDS-UPDRS-III score before and after taking the SSRI\/SNRI medication, while for the control group we compared two equally spaced examinations.\n                    <jats:bold>Results:<\/jats:bold>\n                    In the target group, we found a greater worsening of motor scores, which was associated with lower values of initial LEDD. In addition, apathy was an independent predictor of motor worsening.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    SSRI\/SNRI-use seems to be characterized by a steeper worsening of motor symptoms, which can be predicted by a lower initial LEDD. Further research should continue to investigate the effect of SSRI\/SNRI-use on motor symptoms in PD.\n                  <\/jats:p>","DOI":"10.1177\/1877718x241296016","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:06:19Z","timestamp":1738749979000},"page":"1642-1651","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["The effect of serotonin reuptake and serotonin-noradrenaline reuptake inhibitors on motor symptoms in Parkinson's disease: A PPMI-based matched-subject study"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-1595","authenticated-orcid":false,"given":"Teodora","family":"Mati\u0107","sequence":"first","affiliation":[{"name":"Artificial Intelligence Laboratory, Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Hendriks","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Department of Neurosurgery, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-1849","authenticated-orcid":false,"given":"R Saman","family":"Vinke","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-3556","authenticated-orcid":false,"given":"Aleksander","family":"Sadikov","sequence":"additional","affiliation":[{"name":"Artificial Intelligence Laboratory, Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-3441","authenticated-orcid":false,"given":"Dejan","family":"Georgiev","sequence":"additional","affiliation":[{"name":"Artificial Intelligence Laboratory, Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0409-5"},{"key":"e_1_3_5_3_2","first-page":"27","article-title":"The pros and cons of the SSRI antidepressants","volume":"36","author":"Masterton G","year":"2006","unstructured":"Masterton G. The pros and cons of the SSRI antidepressants. J R Coll Physicians Edinb 2006; 36: 27\u201329.","journal-title":"J R Coll Physicians Edinb"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00035"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.11.001"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006698"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)00030-9"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13040049"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02900.x"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22473"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.07.037"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30140-1"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00435"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182516244"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.8.1216"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.2298\/VSP111114028K"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100325"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200107000-00005"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.1_Part_1.211"},{"key":"e_1_3_5_20_2","article-title":"A case of SSRI induced irreversible parkinsonism","volume":"9","author":"Dixit S","year":"2015","unstructured":"Dixit S, Khan SA, Azad S. A case of SSRI induced irreversible parkinsonism. J Clin Diagn Res 2015; 9: VD01\u2013VD02.","journal-title":"J Clin Diagn Res"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470090607"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200201000-00004"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1359-18"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.10.006"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.4324\/9781315650982"},{"key":"e_1_3_5_27_2","unstructured":"Team RC. A language and environment for statistical computing. R Foundation for Statistical Computing https:\/\/www.R-project.org\/ (2021)."},{"key":"e_1_3_5_28_2","first-page":"437","article-title":"Antidepressants: mechanism of action, toxicity and possible amelioration","volume":"3","author":"Khushboo SB","year":"2017","unstructured":"Khushboo SB, Sharma B. Antidepressants: mechanism of action, toxicity and possible amelioration. J Appl Biotechnol Bioeng 2017; 3: 437\u2013448.","journal-title":"J Appl Biotechnol Bioeng"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1002"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2001.01491.x"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00575"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.04.027"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/ncn3.12051"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70835-1"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.02.003"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.152983"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","unstructured":"Cohn JF Kruez TS Matthews I et al. Detecting depression from facial actions and vocal prosody. In: 2009 3rd International Conference on Affective Computing and Intelligent Interaction and Workshops Amsterdam Netherlands 10\u201312 September 2009 pp.1\u20137. New York: IEEE.","DOI":"10.1109\/ACII.2009.5349358"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.10.019"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00068-3"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.06.014"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.08.002"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12632"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.05.022"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033447"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa181"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5297-x"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100870"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.07.012"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241296016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X241296016","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241296016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:07:30Z","timestamp":1780682850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X241296016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1177\/1877718X241296016"],"URL":"https:\/\/doi.org\/10.1177\/1877718x241296016","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}